Leukemia, Erythroblastic, Acute
"Leukemia, Erythroblastic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Descriptor ID |
D004915
|
| MeSH Number(s) |
C04.557.337.539.275.325 C15.378.190.636.276
|
| Concept/Terms |
Leukemia, Erythroblastic, Acute- Leukemia, Erythroblastic, Acute
- Myeloid Leukemia, Acute, M6
- Erythroleukemia
- Erythroleukemias
- Di Guglielmo's Disease
- Di Guglielmos Disease
- Disease, Di Guglielmo's
- Erythremic Myelosis
- Erythremic Myeloses
- Myeloses, Erythremic
- Myelosis, Erythremic
- Erythroblastic Leukemia, Acute
- Acute Erythroblastic Leukemia
- Acute Erythroblastic Leukemias
- Erythroblastic Leukemias, Acute
- Leukemia, Acute Erythroblastic
- Leukemias, Acute Erythroblastic
- Leukemia, Myeloid, Acute, M6
- Di Guglielmo Disease
- Disease, Di Guglielmo
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Erythroblastic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Erythroblastic, Acute".
This graph shows the total number of publications written about "Leukemia, Erythroblastic, Acute" by people in this website by year, and whether "Leukemia, Erythroblastic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Erythroblastic, Acute" by people in Profiles.
-
GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues. Am J Clin Pathol. 2022 08 04; 158(2):228-234.
-
BET inhibitors enhance embryonic and fetal globin expression in erythroleukemia cell lines. Haematologica. 2021 12 01; 106(12):3223-3227.
-
Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms. Blood. 2021 09 02; 138(9):790-805.
-
Erythroleukemia: an Update. Curr Oncol Rep. 2021 04 20; 23(6):69.
-
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
-
Revisiting erythroleukemia. Curr Opin Hematol. 2017 03; 24(2):146-151.
-
Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant. Pediatr Blood Cancer. 2016 May; 63(5):935-7.
-
Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene. Blood. 2009 Nov 05; 114(19):4233-42.
-
Cell characterization using a protein-functionalized pore. Lab Chip. 2008 Sep; 8(9):1478-85.
-
Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. Blood. 2003 Jan 15; 101(2):524-31.